Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without HIV (PREPARE)

Phase 2 Unknown 300 enrolled St George's, University of London MU-JHU CARE · collab Pfizer · collab

RandomizedParallel-groupQuadruple-blindPrevention

Summary

A placebo controlled clinical trial investigating the safety and immunogenicity of GBS6 in pregnant women with and without human immunodeficiency virus (HIV) infection and their infants

Timeline

Start: 2022-10-14
Primary completion: 2025-09-30
Completion: 2025-09-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	GBS6	Vaccine	20 ug	Intramuscular
Comparator	GBS6	Vaccine	0.5 ml	Intramuscular

Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without HIV (PREPARE)

Summary

Timeline

Drugs

Indications